{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:25:02Z","timestamp":1792697102927,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sickle cell disease (SCD) is commonly encountered in Africa and Middle Eastern countries. The causative mutation in the gene encoding the hemoglobin subunit \u03b2 (HBB) leads to various genotypic variants of the disease. This results in varied phenotypes, with a spectrum of complications, from benign to fatal. Hemoglobin SS (HBSS) genotype is associated with most of these complications; hence, it is a severe form of SCD. On the other hand, rare genotypes such as hemoglobin SE (HBSE) are considered benign. There is limited literature about the clinical manifestations and characteristics of patients with HBSE. We pooled all available data describing the phenotypic manifestations of HBSE heterozygote worldwide to perform a systematic review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a systematic review according to PRISMA guidelines using PubMed, SCOPUS, and Google Scholar databases. Two independent reviewers (FA and IK) evaluated studies for eligibility and extracted data. We synthesized data on demographics, manifestations, and management of HBSE disease. PROSPERO Registration Number: CRD42021229877.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found 68 HBSE patients reported in the literature. 24 cases were extracted from case reports whereas 44 cases from case series and retrospective studies. Turkey reported the highest number of patients (n\u2009=\u200922). 32 (47%) of the patients were males. The mean age was 20.9\u2009\u00b1\u200918.26\u00a0years. The mean HBS and HBE percentages were 61.1%\u2009\u00b1\u20097.25% and 32.3%\u2009\u00b1\u20095.06%, respectively, whereas the mean hemoglobin was 11.64\u2009\u00b1\u20091.73\u00a0g\/dl. Reported manifestations of HBSE disease included acute vaso-occlusive pain crisis (n\u2009=\u200922, 32.3%), splenomegaly (n\u2009=\u200911, 16.1%), hemolytic anemia (n\u2009=\u200910, 14.7%), infections (n\u2009=\u20098. 11.7%), bone infarction (n\u2009=\u20094, 5.8%), gallstones (n\u2009=\u20093, 4.4%), venous thromboembolism (VTE) (n\u2009=\u20092, 2.9%) and stroke (n\u2009=\u20092, 2.9%), and hematuria (n\u2009=\u20092, 2.9%). Death due to HBSE complications was reported in three patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>HBSE is a rare genotypic variant of SCD. It has been considered a benign form; however, there are multiple reports of severe complications. Severe complications observed in HBSE disease include vaso-occlusive crisis, acute chest syndrome, stroke, bone marrow embolism, and death.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12967-021-02931-1","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T10:03:22Z","timestamp":1623837802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Manifestations of HbSE sickle cell disease: a systematic review"],"prefix":"10.1186","volume":"19","author":[{"given":"Ibrahim","family":"Khamees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7121-8574","authenticated-orcid":false,"given":"Fateen","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf T.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"2931_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019;14:263\u201392.","journal-title":"Annu Rev Pathol"},{"key":"2931_CR2","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010.","journal-title":"Nat Rev Dis Primers"},{"key":"2931_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017;390:311\u201323.","journal-title":"Lancet"},{"key":"2931_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/16078454.2020.1714113","volume":"25","author":"Y Wali","year":"2020","unstructured":"Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region. Hematology. 2020;25:55\u201362.","journal-title":"Hematology"},{"key":"2931_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/1535370216636726","volume":"241","author":"A Habara","year":"2016","unstructured":"Habara A, Steinberg MH. Minireview: genetic basis of heterogeneity and severity in sickle cell disease. Exp Biol Med. 2016;241:689\u201396.","journal-title":"Exp Biol Med"},{"key":"2931_CR6","first-page":"2402","volume":"2016","author":"MM Meremikwu","year":"2016","unstructured":"Meremikwu MM, Okomo U. Sickle cell disease. BMJ Clin Evid. 2016;2016:2402.","journal-title":"BMJ Clin Evid"},{"key":"2931_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-2257.2006.00886.x","volume":"29","author":"HH Knox-Macaulay","year":"2007","unstructured":"Knox-Macaulay HH, Ahmed MM, Gravell D, Al-Kindi S, Ganesh A. Sickle cell-haemoglobin E (HbSE) compound heterozygosity: a clinical and haematological study. Int J Lab Hematol. 2007;29:292\u2013301.","journal-title":"Int J Lab Hematol"},{"key":"2931_CR8","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376:2018\u201331.","journal-title":"Lancet"},{"key":"2931_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ajh.20847","volume":"82","author":"D Masiello","year":"2007","unstructured":"Masiello D, Heeney MM, Adewoye AH, Eung SH, Luo HY, Steinberg MH, Chui DH. Hemoglobin SE disease: a concise review. Am J Hematol. 2007;82:643\u20139.","journal-title":"Am J Hematol"},{"key":"2931_CR10","doi-asserted-by":"publisher","DOI":"10.4081\/thal.2015.4597","author":"C Acipayam","year":"2015","unstructured":"Acipayam C, Oktay G, Ilhan G, \u00c7\u00fcr\u00fck MA. Hemoglobin SE disease in Hatay, in the southern part of Turkey. Thal Rep. 2015. https:\/\/doi.org\/10.4081\/thal.2015.4597.","journal-title":"Thal Rep"},{"key":"2931_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1182\/blood.V15.5.610.610","volume":"15","author":"M Aksoy","year":"1960","unstructured":"Aksoy M. The hemoglobin E syndromes II sickle-cell-hemoglobin E disease. Blood. 1960;15:610\u20133.","journal-title":"Blood"},{"key":"2931_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3109\/03630267609031026","volume":"1","author":"C Altay","year":"1976","unstructured":"Altay C, Niazi GA, Huisman TH. The combination of HB S and HB E in a black female. Hemoglobin. 1976;1:100\u20132.","journal-title":"Hemoglobin"},{"key":"2931_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5858\/2005-129-257-PQCAYW","volume":"129","author":"L Andino","year":"2005","unstructured":"Andino L, Risin SA. Pathologic quiz case: a 24-year-old woman with abnormal hemoglobin and thrombocytopenia. Compound heterozygosity for hemoglobin S and E. Arch Pathol Lab Med. 2005;129:257\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"2931_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/PAF.0b013e3181d8e390","volume":"32","author":"EF Arbefeville","year":"2011","unstructured":"Arbefeville EF, Tebbi CK, Chrostowski L, Adams VI. Sudden death after exercise in an adolescent with hemoglobin SE. Am J Forensic Med Pathol. 2011;32:341\u20133.","journal-title":"Am J Forensic Med Pathol"},{"key":"2931_CR15","first-page":"782923","volume":"2014","author":"P Baciu","year":"2014","unstructured":"Baciu P, Yang C, Fantin A, Darnley-Fisch D, Desai U. First reported case of proliferative retinopathy in hemoglobin SE disease. Case Rep Ophthalmol Med. 2014;2014:782923.","journal-title":"Case Rep Ophthalmol Med"},{"key":"2931_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000206374","volume":"72","author":"AR Bird","year":"1984","unstructured":"Bird AR, Wood K, Leisegang F, Mathew CG, Ellis P, Hartley PS, Karabus CD. Haemoglobin E variants: a clinical, haematological and biosynthetic study of 4 South African families. Acta Haematol. 1984;72:135\u20137.","journal-title":"Acta Haematol"},{"key":"2931_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1365-2796.1999.0445f.x","volume":"245","author":"RF Eichhorn","year":"1999","unstructured":"Eichhorn RF, Buurke EJ, Blok P, Berends MJ, Jansen CL. Sickle cell-like crisis and bone marrow necrosis associated with parvovirus B19 infection and heterozygosity for haemoglobins S and E. J Intern Med. 1999;245:103\u20136.","journal-title":"J Intern Med"},{"key":"2931_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00003072-198203000-00002","volume":"7","author":"BL Englestad","year":"1982","unstructured":"Englestad BL. Functional asplenia in hemoglobin SE disease. Clin Nucl Med. 1982;7:100\u20132.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"2931_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/eye.2000.101","volume":"14","author":"A Ganesh","year":"2000","unstructured":"Ganesh A, al-Habsi NS, al-Alawi FK, Mitra S, Eriksson A, Venugopalan P. Traumatic hyphaema and sickle cell retinopathy in a patient with sickle cell-haemoglobin E (HbSE) disease. Eye. 2000;14(3):397\u2013400.","journal-title":"Eye"},{"key":"2931_CR20","first-page":"568","volume":"9","author":"E George","year":"1978","unstructured":"George E, Iqbal QM. Hb ES presenting as avascular necrosis. Southeast Asian J Trop Med Public Health. 1978;9:568\u201370.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2931_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1365-2141.2000.02035.x","volume":"108","author":"R Gupta","year":"2000","unstructured":"Gupta R, Jarvis M, Yardumian A. Compound heterozygosity for haemoglobin S and haemoglobin E. Br J Haematol. 2000;108:463.","journal-title":"Br J Haematol"},{"key":"2931_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ajh.20488","volume":"81","author":"E G\u00fcrkan","year":"2006","unstructured":"G\u00fcrkan E. Vaso-occlusive manifestations in a patient with sickle cell-hemoglobin E (HbSE) disease. Am J Hematol. 2006;81:149.","journal-title":"Am J Hematol"},{"key":"2931_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/03630268508996981","volume":"9","author":"MJ Hardy","year":"1985","unstructured":"Hardy MJ, Ragbeer MS. Homozygous HbE and HbSE disease in a Saudi family. Hemoglobin. 1985;9:47\u201352.","journal-title":"Hemoglobin"},{"key":"2931_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cca.2014.01.028","volume":"431","author":"K Italia","year":"2014","unstructured":"Italia K, Upadhye D, Dabke P, Kangane H, Colaco S, Sawant P, Nadkarni A, Gorakshakar A, Jain D, Italia Y, et al. Clinical and hematological presentation among Indian patients with common hemoglobin variants. Clin Chim Acta. 2014;431:46\u201351.","journal-title":"Clin Chim Acta"},{"key":"2931_CR25","doi-asserted-by":"publisher","DOI":"10.22541\/au.161158119.94954198\/v1","author":"I Khamees","year":"2020","unstructured":"Khamees I, Yassin M, Rozi W. Acute chest syndrome in sickle cell disease\/HBE patient, a case report. Authorea. 2020. https:\/\/doi.org\/10.22541\/au.161158119.94954198\/v1.","journal-title":"Authorea"},{"key":"2931_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00277-005-1044-2","volume":"84","author":"P Mishra","year":"2005","unstructured":"Mishra P, Pati HP, Chatterjee T, Dixit A, Choudhary DR, Srinivas MU, Mahapatra M, Choudhry VP. Hb SE disease: a clinico-hematological profile. Ann Hematol. 2005;84:667\u201370.","journal-title":"Ann Hematol"},{"key":"2931_CR27","first-page":"465","volume":"44","author":"S Mukhopadhyay","year":"2001","unstructured":"Mukhopadhyay S, Kumar N, Saxena R. Sickle cell-hemoglobin E disease in an Indian family. Indian J Pathol Microbiol. 2001;44:465\u20136.","journal-title":"Indian J Pathol Microbiol"},{"key":"2931_CR28","first-page":"e10321","volume":"12","author":"A Pajak","year":"2020","unstructured":"Pajak A, Li JC, Liu A, Nazare S, Smith B. Hemoglobin SE disease presenting as a high-altitude massive splenic infarction complicated by hemorrhagic conversion and splenectomy. Cureus. 2020;12:e10321.","journal-title":"Cureus"},{"key":"2931_CR29","first-page":"493","volume":"71","author":"AJ Ramahi","year":"1988","unstructured":"Ramahi AJ, Lewkow LM, Dombrowski MP, Bottoms SF. Sickle cell E hemoglobinopathy and pregnancy. Obstet Gynecol. 1988;71:493\u20135.","journal-title":"Obstet Gynecol"},{"key":"2931_CR30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ajh.21605","volume":"85","author":"M Rayburg","year":"2010","unstructured":"Rayburg M, Kalinyak KA, Towbin AJ, Baker PB, Joiner CH. Fatal bone marrow embolism in a child with hemoglobin SE disease. Am J Hematol. 2010;85:182\u20134.","journal-title":"Am J Hematol"},{"key":"2931_CR31","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0022-3476(05)83053-7","volume":"119","author":"KS Rey","year":"1991","unstructured":"Rey KS, Unger CA, Rao SP, Miller ST. Sickle cell-hemoglobin E disease: clinical findings and implications. J Pediatr. 1991;119:949\u201351.","journal-title":"J Pediatr"},{"key":"2931_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/03630267709003411","volume":"1","author":"WA Schroeder","year":"1977","unstructured":"Schroeder WA, Powars D, Reynolds RD, Fisher JI. Hb-E in combination with Hb-S and Hb-C in a black family. Hemoglobin. 1977;1:287\u20139.","journal-title":"Hemoglobin"},{"key":"2931_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2016.11929447","author":"A Smith","year":"2016","unstructured":"Smith A, Cooper B, Guileyardo J, Mora A Jr. Unrecognized hemoglobin SE disease as microcytosis. Bayl Univ Med Cent Proc. 2016. https:\/\/doi.org\/10.1080\/08998280.2016.11929447.","journal-title":"Bayl Univ Med Cent Proc"},{"key":"2931_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/08880018.2012.655406","volume":"29","author":"RY Tamminga","year":"2012","unstructured":"Tamminga RY, Doornbos ME, Muskiet FA, Koetse HA. Rhabdomyolysis in a child with hemoglobin SE. Pediatr Hematol Oncol. 2012;29:267\u20139.","journal-title":"Pediatr Hematol Oncol"},{"key":"2931_CR35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.47102\/annals-acadmedsg.V40N12p552","volume":"40","author":"SH Tay","year":"2011","unstructured":"Tay SH, Teng GG, Poon M, Lee VK, Lim AY. A case of hemoglobin SE presenting with sickle cell crisis: case report and histological correlation. Ann Acad Med Singap. 2011;40:552\u20133.","journal-title":"Ann Acad Med Singap"},{"key":"2931_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/MPH.0b013e31819af9db","volume":"31","author":"CD Thornburg","year":"2009","unstructured":"Thornburg CD, Steinberg MH, Chui DH. Hemoglobin SE disease in Maine, and severe thalassemia in New Hampshire. J Pediatr Hematol Oncol. 2009;31:307.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2931_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2016","unstructured":"Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, et al. Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med. 2016;376:429\u201339.","journal-title":"N Engl J Med"},{"key":"2931_CR38","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1903212","volume":"381","author":"E Vichinsky","year":"2019","unstructured":"Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, et al. A phase 3 randomized trial of voxelotor in sickle cell disease. N Engl J Med. 2019;381:509\u201319.","journal-title":"N Engl J Med"},{"key":"2931_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-med-041817-125507","volume":"70","author":"SH Orkin","year":"2019","unstructured":"Orkin SH, Bauer DE. Emerging genetic therapy for sickle cell disease. Annu Rev Med. 2019;70:257\u201371.","journal-title":"Annu Rev Med"},{"issue":"10","key":"2931_CR40","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.11124\/JBISRIR-D-19-00099","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127\u201333.","journal-title":"JBI Evid Synth"},{"key":"2931_CR41","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/B978-1-4377-0134-0.10077-0","volume-title":"Avery\u2019s diseases of the newborn","author":"DC Matthews","year":"2012","unstructured":"Matthews DC, Glader B. Erythrocyte disorders in infancy. In: Gleason CA, Devaskar SU, editors. Avery\u2019s diseases of the newborn. 9th ed. Philadelpia: W.B. Saunders; 2012. p. 1080\u2013107.","edition":"9"},{"key":"2931_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/B978-0-323-03454-8.50050-4","volume-title":"Immigrant medicine","author":"R Hurley","year":"2007","unstructured":"Hurley R. Anemia and red blood cell disorders. In: Walker PF, Barnett ED, editors. Immigrant medicine. Edinburgh: W.B. Saunders; 2007. p. 611\u201323."},{"key":"2931_CR43","first-page":"704","volume":"79","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79:704\u201312.","journal-title":"Bull World Health Organ"},{"key":"2931_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1535370216640385","volume":"241","author":"CT Quinn","year":"2016","unstructured":"Quinn CT. Minireview: clinical severity in sickle cell disease: the challenges of definition and prognostication. Exp Biol Med. 2016;241:679\u201388.","journal-title":"Exp Biol Med"},{"key":"2931_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/CH-189004","volume":"68","author":"AK Chang","year":"2018","unstructured":"Chang AK, Ginter Summarell CC, Birdie PT, Sheehan VA. Genetic modifiers of severity in sickle cell disease. Clin Hemorheol Microcirc. 2018;68:147\u201364.","journal-title":"Clin Hemorheol Microcirc"},{"key":"2931_CR46","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.111.032920","volume":"124","author":"V Sachdev","year":"2011","unstructured":"Sachdev V, Kato GJ, Gibbs JS, Barst RJ, Machado RF, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, et al. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation. 2011;124:1452\u201360.","journal-title":"Circulation"},{"key":"2931_CR47","first-page":"895","volume":"29","author":"C Vishwanathan","year":"1992","unstructured":"Vishwanathan C, Agarwal MB, Bichile LS, Bhave AB. Double heterozygosity for hemoglobin S and E. Indian Pediatr. 1992;29:895\u20137.","journal-title":"Indian Pediatr"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-021-02931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-021-02931-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-021-02931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T22:24:47Z","timestamp":1725229487000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-021-02931-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2931"],"URL":"https:\/\/doi.org\/10.1186\/s12967-021-02931-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"27 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}